1. Dual Drug Loaded Potassium-contained Graphene Oxide as a Nanocarrier in Cocktailed Drug Delivery for the Treatment of Human Breast Cancer
   Himani Tiwari et al, 2023, Current Drug Delivery CrossRef
2. Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
   Nilesh Kumar Sharma et al, 2024, Cancers CrossRef
3. Nanofibrous silica microparticles/polymer hybrid aerogels for sustained delivery of poorly water-soluble camptothecin
   Heveline D.M. Follmann et al, 2020, Journal of Colloid and Interface Science CrossRef
4. Dual inhibitors of epidermal growth factor receptor and topoisomerase IIα derived from a quinoline scaffold
   Monika Chauhan et al, 2016, RSC Advances CrossRef
5. Bilberry extract, its major polyphenolic compounds, and the soy isoflavone genistein antagonize the cytostatic drug erlotinib in human epithelial cells
   G. Aichinger et al, 2016, Food & Function CrossRef
6. Systematic analysis of the potential off-target activities of osimertinib by computational target fishing
   Shao-jun Chen et al, 2022, Anti-Cancer Drugs CrossRef
7. Polyphenols as Key Players for the Antileukaemic Effects of Propolis
   Murtala B. Abubakar et al, 2014, Evidence-Based Complementary and Alternative Medicine CrossRef
8. Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors
   Refael Peleg et al, 2014, BMC Cancer CrossRef
9. Interpreting drug synergy in breast cancer with deep learning using target-protein inhibition profiles
   Thanyawee Srithanyarat et al, 2024, BioData Mining CrossRef
10. DNA Topoisomerase IB as a Potential Ionizing Radiation Exposure and Dose Biomarker
    Rotem Daudee et al, 2018, Radiation Research CrossRef
11. CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
    Alexander H. Chung et al, 2019, Cancer Cell International CrossRef